Gastric Bypass Stent System Market Report 2026

Gastric Bypass Stent System Market Overview

• Gastric Bypass Stent System market size has reached to $0.41 billion in 2025 • Expected to grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Rising Obesity Prevalence Driving Growth Of The Market Due To Unhealthy Diets And Sedentary Lifestyles • Market Trend: Innovative Gastric Bypass Stent Technologies Enhance Minimally Invasive Obesity Treatment And Weight Management Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastric Bypass Stent System Market?

A gastric bypass stent system is a specialized medical device placed in the gastrointestinal tract to support or maintain an open passage after gastric bypass surgery or related procedures. It is commonly used to manage complications such as leaks, strictures, or blockages, helping improve healing and restore normal food flow with minimally invasive treatment. The main product types of gastric bypass stent system include fully covered stents, partially covered stents, and uncovered stents. Fully covered stents refer to implantable medical devices designed to maintain gastrointestinal patency while preventing tissue ingrowth during gastric bypass procedures. These stents are made using materials such as stainless steel, nitinol, and polymer and are distributed through direct sales, medical distributors, and online medical supply platforms. The various applications involved are obesity management, obstruction relief, and gastrointestinal disorders, and they are used by several end users such as hospitals, ambulatory surgical centers, and specialty clinics.

What Is The Gastric Bypass Stent System Market Growth Forecast?

The gastric bypass stent system market size is expected to see rapid growth in the next few years. It will grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing adoption of precision medicine in gastrointestinal care, rising demand for biodegradable and biocompatible stent materials, growth in robotic assisted endoscopic procedures, expansion of ambulatory surgical centers for faster recovery treatments, integration of AI based diagnostic support in gastrointestinal interventions. Major trends in the forecast period include increasing adoption of minimally invasive gastrointestinal stenting procedures for post bariatric surgery complications, growing preference for self expanding nitinol stents due to flexibility and reduced migration risk, rising use of fully covered stents for improved leak management and tissue healing, expansion of hospital based endoscopic intervention procedures for obesity related complications, increasing demand for advanced biodegradable stent materials to reduce long term device removal risks.

Global Gastric Bypass Stent System Market Segmentation

1) By Product Type: Fully Covered Stents; Partially Covered Stents; Uncovered Stents 2) By Material: Stainless Steel; Nitinol; Polymer 3) By Distribution Channel: Direct Sales; Medical Distributors; Online Medical Supply Platforms 4) By Application: Obesity Management; Obstruction Relief; Gastrointestinal Disorders 5) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics Subsegments: 1) By Fully Covered Stents: Drug Eluting Fully Covered Stents; Biodegradable Fully Covered Stents; Anti Migration Flared End Fully Covered Stents 2) By Partially Covered Stents: Nitinol Based Partially Covered Self Expanding Stents; Flared End Partially Covered Stents For Anchoring; Anti Migration Partially Covered Stents With Uncovered Mesh Ends 3) By Uncovered Stents: Bare Metal Self Expanding Stents; Nitinol Wire Mesh Stents; Stainless Steel Woven Stents

What Are The Drivers Of The Gastric Bypass Stent System Market?

The rising prevalence of obesity is expected to propel the growth of the gastric bypass stent system market going forward. Obesity is a medical condition in which excess body fat accumulates to a level that can harm health, usually indicated by a BMI of 30 or higher. Obesity is increasing mainly due to high consumption of processed, calorie-dense foods combined with reduced physical activity in modern sedentary lifestyles, leading to more energy intake than the body burns. Gastric bypass stent systems help manage obesity by creating a temporary passage in the digestive tract that reduces food absorption and promotes early fullness, enabling patients to lose weight without undergoing permanent invasive bariatric surgery. For instance, in March 2025, according to the World Obesity Federation, a UK-based membership organization, by 2030, nearly 3 billion adults, around 50% of the global adult population, will be affected by overweight or obesity. Therefore, the rising prevalence of obesity is driving the growth of the gastric bypass stent system industry. The increasing adoption of minimally invasive procedures is expected to propel the growth of the gastric bypass stent system market going forward. Minimally invasive procedures are medical treatments performed through small incisions or natural openings using specialized tools to reduce pain, tissue damage, and recovery time compared to open surgery. Minimally invasive procedures are increasing due to advancements in medical technology, which make them safer, more precise, and suitable for a wider range of treatments. Gastric bypass stent systems help make minimally invasive procedures by providing a non-surgical or endoscopic approach to managing obesity and gastrointestinal complications, reducing the need for open surgery, minimizing tissue damage, shortening recovery time, and lowering the risk of postoperative complications. For instance, in September 2023, according to the National Library of Medicine, a US-based federal government agency, 7,733 robotic surgical systems were installed worldwide, and more than 10 million robotic surgeries have been carried out. Therefore, the increasing adoption of minimally invasive procedures is driving the growth of the gastric bypass stent system industry.

Key Players In The Global Gastric Bypass Stent System Market

Major companies operating in the gastric bypass stent system market are Hangzhou Tongee Medical Technology Co. Ltd.; Boston Scientific; Cook Medical; Olympus Corporation; Medtronic

Global Gastric Bypass Stent System Market Trends and Insights

Major companies operating in the gastric bypass stent system market are focusing on developing advanced minimally invasive obesity treatment solutions to improve weight management outcomes, reduce surgical complications, and enhance patient recovery. Minimally invasive obesity treatment refers to advanced medical procedures that support weight reduction through less invasive techniques, minimizing surgical trauma, recovery time, and complication risks compared to conventional bariatric surgery. For instance, in April 2024, Hangzhou Tongee Medical Technology Co., Ltd., a China-based medical device company, received approval from China’s National Medical Products Administration (NMPA) for its innovative Gastric Bypass Stent System. The system consists of delivery and retrieval components and is designed to isolate the contact between chyme and the intestinal tract, achieving effects similar to gastric bypass surgery without changing the physiological structure of the gastrointestinal tract. The device is intended for obesity patients with ineffective lifestyle modification and poor response to non-invasive or drug treatments, providing a new minimally invasive option for obesity management.

Regional Outlook

North America was the largest region in the gastric bypass stent system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastric Bypass Stent System Market?

The gastric bypass stent system market consists of sales of lumen-apposing stents, anti-migration stent systems, and drug-eluting stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastric Bypass Stent System Market Report 2026?

The gastric bypass stent system market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastric bypass stent system industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.